Share Price and Basic Stock Data
Last Updated: August 1, 2025, 2:44 pm
PEG Ratio | 0.66 |
---|
Quick Insight
Balmer Lawrie Investment Ltd, a non-banking financial company, currently trades at ₹84.1 with a market capitalization of ₹1,868 Cr. With a P/E ratio of 10.9, the company's return on equity stands at 13.2% and return on capital employed at 17.3%. Operating profit margin is at 16%, while net profit is reported at ₹267 Cr. Furthermore, the company holds reserves worth ₹1,354 Cr and carries borrowings of ₹106 Cr. Notably, the current price-to-book value ratio is 1.09x, indicating potential undervaluation. With a comfortable interest coverage ratio of 14.04x and a reasonably efficient cash conversion cycle of 37 days, Balmer Lawrie Investment Ltd demonstrates a strong financial position, supported by healthy profitability metrics and manageable leverage levels.
Competitors of Balmer Lawrie Investment Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Minolta Finance Ltd | 11.8 Cr. | 1.18 | 1.91/0.72 | 1,180 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 |
Money Masters Leasing & Finance Ltd | 17.7 Cr. | 1.76 | 18.8/1.06 | 34.6 | 1.57 | 0.00 % | 2.44 % | 3.58 % | 1.00 |
Moneyboxx Finance Ltd | 506 Cr. | 155 | 331/152 | 79.8 | 0.00 % | 8.73 % | 0.58 % | 10.0 | |
Moongipa Capital Finance Ltd | 17.0 Cr. | 18.5 | 41.0/18.0 | 12.3 | 24.9 | 0.00 % | 15.0 % | 9.43 % | 10.0 |
Morarka Finance Ltd | 50.2 Cr. | 112 | 191/95.0 | 38.9 | 212 | 5.38 % | 2.46 % | 2.17 % | 10.0 |
Industry Average | 25,037.97 Cr | 472.73 | 78.29 | 498.63 | 0.26% | 15.73% | 8.87% | 8.48 |
Quarterly Result
Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 577 | 649 | 553 | 516 | 610 | 594 | 587 | 587 | 579 | 641 | 642 | 633 | 611 |
Expenses | 518 | 587 | 513 | 464 | 556 | 528 | 511 | 511 | 485 | 574 | 569 | 547 | 514 |
Operating Profit | 58 | 62 | 40 | 52 | 55 | 67 | 77 | 76 | 94 | 66 | 73 | 86 | 97 |
OPM % | 10% | 10% | 7% | 10% | 9% | 11% | 13% | 13% | 16% | 10% | 11% | 14% | 16% |
Other Income | 33 | 24 | 24 | 15 | 35 | 24 | 28 | 27 | 30 | 31 | 29 | 22 | 33 |
Interest | 3 | 5 | 4 | 5 | 5 | 6 | 5 | 5 | 6 | 6 | 5 | 9 | 6 |
Depreciation | 14 | 14 | 14 | 14 | 14 | 15 | 14 | 14 | 15 | 14 | 14 | 15 | 16 |
Profit before tax | 74 | 68 | 46 | 47 | 70 | 70 | 85 | 83 | 103 | 76 | 82 | 84 | 107 |
Tax % | 36% | 17% | 24% | 22% | 38% | 18% | 25% | 19% | 27% | 15% | 24% | 24% | 30% |
Net Profit | 47 | 56 | 35 | 37 | 44 | 57 | 64 | 68 | 75 | 65 | 63 | 64 | 75 |
EPS in Rs | 1.35 | 1.60 | 1.02 | 1.10 | 1.27 | 1.66 | 1.83 | 1.94 | 2.14 | 1.86 | 1.82 | 1.88 | 2.17 |
Last Updated: May 31, 2025, 6:48 am
Below is a detailed analysis of the quarterly data for Balmer Lawrie Investment Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 611.00 Cr.. The value appears to be declining and may need further review. It has decreased from 633.00 Cr. (Dec 2024) to 611.00 Cr., marking a decrease of 22.00 Cr..
- For Expenses, as of Mar 2025, the value is 514.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 547.00 Cr. (Dec 2024) to 514.00 Cr., marking a decrease of 33.00 Cr..
- For Operating Profit, as of Mar 2025, the value is 97.00 Cr.. The value appears strong and on an upward trend. It has increased from 86.00 Cr. (Dec 2024) to 97.00 Cr., marking an increase of 11.00 Cr..
- For OPM %, as of Mar 2025, the value is 16.00%. The value appears strong and on an upward trend. It has increased from 14.00% (Dec 2024) to 16.00%, marking an increase of 2.00%.
- For Other Income, as of Mar 2025, the value is 33.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Dec 2024) to 33.00 Cr., marking an increase of 11.00 Cr..
- For Interest, as of Mar 2025, the value is 6.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 9.00 Cr. (Dec 2024) to 6.00 Cr., marking a decrease of 3.00 Cr..
- For Depreciation, as of Mar 2025, the value is 16.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 15.00 Cr. (Dec 2024) to 16.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 107.00 Cr.. The value appears strong and on an upward trend. It has increased from 84.00 Cr. (Dec 2024) to 107.00 Cr., marking an increase of 23.00 Cr..
- For Tax %, as of Mar 2025, the value is 30.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Dec 2024) to 30.00%, marking an increase of 6.00%.
- For Net Profit, as of Mar 2025, the value is 75.00 Cr.. The value appears strong and on an upward trend. It has increased from 64.00 Cr. (Dec 2024) to 75.00 Cr., marking an increase of 11.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is 2.17. The value appears strong and on an upward trend. It has increased from 1.88 (Dec 2024) to 2.17, marking an increase of 0.29.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: June 16, 2025, 2:40 pm
Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|
Sales | 1,817 | 1,573 | 1,563 | 2,074 | 2,335 | 2,373 | 2,526 |
Expenses | 1,547 | 1,347 | 1,413 | 1,883 | 2,110 | 2,024 | 2,204 |
Operating Profit | 270 | 226 | 150 | 191 | 225 | 349 | 322 |
OPM % | 15% | 14% | 10% | 9% | 10% | 15% | 13% |
Other Income | 58 | 59 | 79 | 65 | 81 | 73 | 115 |
Interest | 7 | 15 | 12 | 14 | 18 | 22 | 27 |
Depreciation | 30 | 52 | 55 | 57 | 57 | 59 | 60 |
Profit before tax | 290 | 218 | 162 | 186 | 232 | 341 | 350 |
Tax % | 30% | 26% | 26% | 26% | 26% | 23% | 24% |
Net Profit | 202 | 161 | 121 | 137 | 172 | 264 | 267 |
EPS in Rs | 5.79 | 4.76 | 3.59 | 3.97 | 5.00 | 7.57 | 7.73 |
Dividend Payout % | 59% | 79% | 106% | 75% | 66% | 50% | 56% |
YoY Net Profit Growth
Year | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | -20.30% | -24.84% | 13.22% | 25.55% | 53.49% | 1.14% |
Change in YoY Net Profit Growth (%) | 0.00% | -4.55% | 38.07% | 12.32% | 27.94% | -52.35% |
Balmer Lawrie Investment Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2019-2020 to 2024-2025.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 10% |
3 Years: | 7% |
TTM: | 6% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 10% |
3 Years: | 26% |
TTM: | 2% |
Stock Price CAGR | |
---|---|
10 Years: | 11% |
5 Years: | 16% |
3 Years: | 29% |
1 Year: | -20% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 11% |
3 Years: | 12% |
Last Year: | 13% |
Last Updated: Unknown
Balance Sheet
Last Updated: July 25, 2025, 1:45 pm
Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|
Equity Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 |
Reserves | 1,052 | 1,081 | 1,076 | 1,094 | 1,117 | 1,199 | 1,354 |
Borrowings | 81 | 122 | 125 | 122 | 121 | 113 | 106 |
Other Liabilities | 1,266 | 1,256 | 1,304 | 1,340 | 1,540 | 1,691 | 1,720 |
Total Liabilities | 2,420 | 2,482 | 2,527 | 2,578 | 2,801 | 3,025 | 3,201 |
Fixed Assets | 568 | 770 | 767 | 767 | 760 | 751 | 737 |
CWIP | 117 | 24 | 32 | 11 | 28 | 52 | 67 |
Investments | 325 | 375 | 386 | 436 | 518 | 565 | 632 |
Other Assets | 1,410 | 1,313 | 1,341 | 1,364 | 1,495 | 1,657 | 1,766 |
Total Assets | 2,420 | 2,482 | 2,527 | 2,578 | 2,801 | 3,025 | 3,201 |
Below is a detailed analysis of the balance sheet data for Balmer Lawrie Investment Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 22.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 22.00 Cr..
- For Reserves, as of Mar 2025, the value is 1,354.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,199.00 Cr. (Mar 2024) to 1,354.00 Cr., marking an increase of 155.00 Cr..
- For Borrowings, as of Mar 2025, the value is 106.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 113.00 Cr. (Mar 2024) to 106.00 Cr., marking a decrease of 7.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 1,720.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,691.00 Cr. (Mar 2024) to 1,720.00 Cr., marking an increase of 29.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 3,201.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,025.00 Cr. (Mar 2024) to 3,201.00 Cr., marking an increase of 176.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 737.00 Cr.. The value appears to be declining and may need further review. It has decreased from 751.00 Cr. (Mar 2024) to 737.00 Cr., marking a decrease of 14.00 Cr..
- For CWIP, as of Mar 2025, the value is 67.00 Cr.. The value appears strong and on an upward trend. It has increased from 52.00 Cr. (Mar 2024) to 67.00 Cr., marking an increase of 15.00 Cr..
- For Investments, as of Mar 2025, the value is 632.00 Cr.. The value appears strong and on an upward trend. It has increased from 565.00 Cr. (Mar 2024) to 632.00 Cr., marking an increase of 67.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,766.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,657.00 Cr. (Mar 2024) to 1,766.00 Cr., marking an increase of 109.00 Cr..
- For Total Assets, as of Mar 2025, the value is 3,201.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,025.00 Cr. (Mar 2024) to 3,201.00 Cr., marking an increase of 176.00 Cr..
Notably, the Reserves (1,354.00 Cr.) exceed the Borrowings (106.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|
Free Cash Flow | 189.00 | 104.00 | 25.00 | 69.00 | 104.00 | 236.00 | 216.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|
Debtor Days | 56 | 63 | 67 | 55 | 56 | 66 |
Inventory Days | 47 | 58 | 58 | 51 | 47 | 47 |
Days Payable | 0 | 88 | 99 | 68 | 69 | 75 |
Cash Conversion Cycle | 102 | 33 | 27 | 38 | 35 | 37 |
Working Capital Days | 42 | 51 | 32 | 51 | 41 | 42 |
ROCE % | 13% | 9% | 11% | 13% | 18% |
This stock is not held by any mutual fund.
Key Financial Ratios
Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
---|---|---|---|---|---|
FaceValue | 1.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 0.77 | 75.68 | 49.98 | 39.88 | 35.92 |
Diluted EPS (Rs.) | 0.77 | 75.68 | 49.98 | 39.88 | 35.92 |
Cash EPS (Rs.) | 11.82 | 119.31 | 75.86 | 66.88 | 64.41 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 61.98 | 549.97 | 500.91 | 788.73 | 777.64 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 61.98 | 549.97 | 500.91 | 788.73 | 777.64 |
Revenue From Operations / Share (Rs.) | 113.81 | 1057.87 | 1048.95 | 928.38 | 692.07 |
PBDIT / Share (Rs.) | 16.78 | 164.10 | 110.61 | 94.86 | 88.56 |
PBIT / Share (Rs.) | 14.06 | 137.44 | 85.02 | 69.73 | 63.78 |
PBT / Share (Rs.) | 12.87 | 127.51 | 76.94 | 63.60 | 58.41 |
Net Profit / Share (Rs.) | 9.10 | 92.65 | 50.28 | 41.74 | 39.62 |
NP After MI And SOA / Share (Rs.) | 7.73 | 75.68 | 49.98 | 39.88 | 35.92 |
PBDIT Margin (%) | 14.74 | 15.51 | 10.54 | 10.21 | 12.79 |
PBIT Margin (%) | 12.35 | 12.99 | 8.10 | 7.51 | 9.21 |
PBT Margin (%) | 11.30 | 12.05 | 7.33 | 6.85 | 8.43 |
Net Profit Margin (%) | 7.99 | 8.75 | 4.79 | 4.49 | 5.72 |
NP After MI And SOA Margin (%) | 6.79 | 7.15 | 4.76 | 4.29 | 5.18 |
Return on Networth / Equity (%) | 12.47 | 13.76 | 9.97 | 7.92 | 7.26 |
Return on Capital Employeed (%) | 12.47 | 13.21 | 8.76 | 7.56 | 7.09 |
Return On Assets (%) | 5.36 | 5.55 | 3.96 | 3.43 | 3.15 |
Long Term Debt / Equity (X) | 0.05 | 0.05 | 0.07 | 0.07 | 0.08 |
Total Debt / Equity (X) | 0.05 | 0.06 | 0.08 | 0.08 | 0.08 |
Asset Turnover Ratio (%) | 0.81 | 0.80 | 0.86 | 0.05 | 0.06 |
Current Ratio (X) | 2.49 | 2.29 | 2.29 | 2.54 | 2.51 |
Quick Ratio (X) | 2.22 | 2.02 | 1.98 | 2.16 | 2.20 |
Inventory Turnover Ratio (X) | 8.30 | 7.48 | 7.88 | 0.00 | 0.00 |
Dividend Payout Ratio (NP) (%) | 0.00 | 43.60 | 60.02 | 95.29 | 104.40 |
Dividend Payout Ratio (CP) (%) | 0.00 | 32.24 | 39.70 | 58.45 | 61.77 |
Earning Retention Ratio (%) | 0.00 | 56.40 | 39.98 | 4.71 | -4.40 |
Cash Earning Retention Ratio (%) | 0.00 | 67.76 | 60.30 | 41.55 | 38.23 |
Interest Coverage Ratio (X) | 14.04 | 16.52 | 13.69 | 15.49 | 16.50 |
Interest Coverage Ratio (Post Tax) (X) | 8.62 | 10.33 | 7.22 | 7.82 | 8.38 |
Enterprise Value (Cr.) | 1724.29 | 1534.20 | 1027.01 | 1008.40 | 1085.04 |
EV / Net Operating Revenue (X) | 0.68 | 0.65 | 0.44 | 0.48 | 0.70 |
EV / EBITDA (X) | 4.63 | 4.21 | 4.18 | 4.79 | 5.52 |
MarketCap / Net Operating Revenue (X) | 0.59 | 0.57 | 0.33 | 0.39 | 0.67 |
Retention Ratios (%) | 0.00 | 56.39 | 39.97 | 4.70 | -4.40 |
Price / BV (X) | 1.09 | 1.11 | 0.70 | 0.73 | 0.94 |
Price / Net Operating Revenue (X) | 0.59 | 0.57 | 0.33 | 0.39 | 0.67 |
EarningsYield | 0.11 | 0.12 | 0.14 | 0.10 | 0.07 |
After reviewing the key financial ratios for Balmer Lawrie Investment Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 10.00 (Mar 24) to 1.00, marking a decrease of 9.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 5. It has decreased from 75.68 (Mar 24) to 0.77, marking a decrease of 74.91.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 5. It has decreased from 75.68 (Mar 24) to 0.77, marking a decrease of 74.91.
- For Cash EPS (Rs.), as of Mar 25, the value is 11.82. This value is within the healthy range. It has decreased from 119.31 (Mar 24) to 11.82, marking a decrease of 107.49.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.98. It has decreased from 549.97 (Mar 24) to 61.98, marking a decrease of 487.99.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 61.98. It has decreased from 549.97 (Mar 24) to 61.98, marking a decrease of 487.99.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 113.81. It has decreased from 1,057.87 (Mar 24) to 113.81, marking a decrease of 944.06.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 16.78. This value is within the healthy range. It has decreased from 164.10 (Mar 24) to 16.78, marking a decrease of 147.32.
- For PBIT / Share (Rs.), as of Mar 25, the value is 14.06. This value is within the healthy range. It has decreased from 137.44 (Mar 24) to 14.06, marking a decrease of 123.38.
- For PBT / Share (Rs.), as of Mar 25, the value is 12.87. This value is within the healthy range. It has decreased from 127.51 (Mar 24) to 12.87, marking a decrease of 114.64.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 9.10. This value is within the healthy range. It has decreased from 92.65 (Mar 24) to 9.10, marking a decrease of 83.55.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.73. This value is within the healthy range. It has decreased from 75.68 (Mar 24) to 7.73, marking a decrease of 67.95.
- For PBDIT Margin (%), as of Mar 25, the value is 14.74. This value is within the healthy range. It has decreased from 15.51 (Mar 24) to 14.74, marking a decrease of 0.77.
- For PBIT Margin (%), as of Mar 25, the value is 12.35. This value is within the healthy range. It has decreased from 12.99 (Mar 24) to 12.35, marking a decrease of 0.64.
- For PBT Margin (%), as of Mar 25, the value is 11.30. This value is within the healthy range. It has decreased from 12.05 (Mar 24) to 11.30, marking a decrease of 0.75.
- For Net Profit Margin (%), as of Mar 25, the value is 7.99. This value is within the healthy range. It has decreased from 8.75 (Mar 24) to 7.99, marking a decrease of 0.76.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.79. This value is below the healthy minimum of 8. It has decreased from 7.15 (Mar 24) to 6.79, marking a decrease of 0.36.
- For Return on Networth / Equity (%), as of Mar 25, the value is 12.47. This value is below the healthy minimum of 15. It has decreased from 13.76 (Mar 24) to 12.47, marking a decrease of 1.29.
- For Return on Capital Employeed (%), as of Mar 25, the value is 12.47. This value is within the healthy range. It has decreased from 13.21 (Mar 24) to 12.47, marking a decrease of 0.74.
- For Return On Assets (%), as of Mar 25, the value is 5.36. This value is within the healthy range. It has decreased from 5.55 (Mar 24) to 5.36, marking a decrease of 0.19.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.05.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.05. This value is within the healthy range. It has decreased from 0.06 (Mar 24) to 0.05, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.81. It has increased from 0.80 (Mar 24) to 0.81, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 2.49. This value is within the healthy range. It has increased from 2.29 (Mar 24) to 2.49, marking an increase of 0.20.
- For Quick Ratio (X), as of Mar 25, the value is 2.22. This value exceeds the healthy maximum of 2. It has increased from 2.02 (Mar 24) to 2.22, marking an increase of 0.20.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.30. This value exceeds the healthy maximum of 8. It has increased from 7.48 (Mar 24) to 8.30, marking an increase of 0.82.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 43.60 (Mar 24) to 0.00, marking a decrease of 43.60.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 32.24 (Mar 24) to 0.00, marking a decrease of 32.24.
- For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 56.40 (Mar 24) to 0.00, marking a decrease of 56.40.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 67.76 (Mar 24) to 0.00, marking a decrease of 67.76.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 14.04. This value is within the healthy range. It has decreased from 16.52 (Mar 24) to 14.04, marking a decrease of 2.48.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 8.62. This value is within the healthy range. It has decreased from 10.33 (Mar 24) to 8.62, marking a decrease of 1.71.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,724.29. It has increased from 1,534.20 (Mar 24) to 1,724.29, marking an increase of 190.09.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.68. This value is below the healthy minimum of 1. It has increased from 0.65 (Mar 24) to 0.68, marking an increase of 0.03.
- For EV / EBITDA (X), as of Mar 25, the value is 4.63. This value is below the healthy minimum of 5. It has increased from 4.21 (Mar 24) to 4.63, marking an increase of 0.42.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 24) to 0.59, marking an increase of 0.02.
- For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 56.39 (Mar 24) to 0.00, marking a decrease of 56.39.
- For Price / BV (X), as of Mar 25, the value is 1.09. This value is within the healthy range. It has decreased from 1.11 (Mar 24) to 1.09, marking a decrease of 0.02.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.59. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 24) to 0.59, marking an increase of 0.02.
- For EarningsYield, as of Mar 25, the value is 0.11. This value is below the healthy minimum of 5. It has decreased from 0.12 (Mar 24) to 0.11, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Balmer Lawrie Investment Ltd:
- Net Profit Margin: 7.99%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.47% (Industry Average ROCE: 15.73%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 12.47% (Industry Average ROE: 8.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 8.62
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.22
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 10.9 (Industry average Stock P/E: 78.29)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.05
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.99%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Non-Banking Financial Company (NBFC) | 21, Netaji Subhas Road, Kolkata West Bengal 700001 | lahoti.a@balmerlawrie.com http://www.blinv.com |
Management | |
---|---|
Name | Position Held |
Mr. Saurav Dutta | Non Executive Chairman |
Mr. Arvind Nath Jha | Government Nominee Director |
Mr. Samir Kumar Mohanty | Government Nominee Director |
FAQ
What is the intrinsic value of Balmer Lawrie Investment Ltd?
Balmer Lawrie Investment Ltd's intrinsic value (as of 02 August 2025) is 74.59 11.52% lower the current market price of 84.30, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,870 Cr. market cap, FY2025-2026 high/low of 107/60.0, reserves of 1,354 Cr, and liabilities of 3,201 Cr.
What is the Market Cap of Balmer Lawrie Investment Ltd?
The Market Cap of Balmer Lawrie Investment Ltd is 1,870 Cr..
What is the current Stock Price of Balmer Lawrie Investment Ltd as on 02 August 2025?
The current stock price of Balmer Lawrie Investment Ltd as on 02 August 2025 is 84.3.
What is the High / Low of Balmer Lawrie Investment Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Balmer Lawrie Investment Ltd stocks is ₹107/60.0.
What is the Stock P/E of Balmer Lawrie Investment Ltd?
The Stock P/E of Balmer Lawrie Investment Ltd is 10.9.
What is the Book Value of Balmer Lawrie Investment Ltd?
The Book Value of Balmer Lawrie Investment Ltd is 62.0.
What is the Dividend Yield of Balmer Lawrie Investment Ltd?
The Dividend Yield of Balmer Lawrie Investment Ltd is 4.52 %.
What is the ROCE of Balmer Lawrie Investment Ltd?
The ROCE of Balmer Lawrie Investment Ltd is 17.3 %.
What is the ROE of Balmer Lawrie Investment Ltd?
The ROE of Balmer Lawrie Investment Ltd is 13.2 %.
What is the Face Value of Balmer Lawrie Investment Ltd?
The Face Value of Balmer Lawrie Investment Ltd is 1.00.